Related Experiment Videos
The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. rhazan@smtplink.mssm.edu
Abstract:
Alterations in the expression or function of molecules that affect cellular adhesion and proliferation are thought to be critical events for tumor progression. Loss of expression of the cell adhesion molecule E-cadherin and increased expression of the epidermal growth factor receptor are two prominent molecular events that are associated with tumorigenesis. The regulation of E-cadherin-dependent cell adhesion by epidermal growth factor (EGF) was therefore examined in the human breast cancer cell line, MDA-MB-468. In this study, changes were observed in the subcellular distribution of components that mediate the cytoplasmic connection between E-cadherin and the actin-based cytoskeleton in response to activation of the EGF receptor. Serum withdrawal activated E-cadherin-dependent cell-cell aggregation in MDA-MB-468 cells, and this treatment stimulated the interaction of actin, alpha-actinin, and vinculin with E-cadherin complexes, despite the absence of alpha-catenin in these cells. By contrast, the co-precipitation of actin with E-cadherin was not detected in several alpha-catenin positive epithelial cell lines. Treatment with EGF inhibited cellular aggregation but did not affect either the levels of E-cadherin or catenin expression nor the association of catenins (beta-catenin, plakoglobin/gamma-catenin, or p120(cas)) with E-cadherin. However, EGF treatment of the MDA-MB-468 cell line dissociated actin, alpha-actinin, and vinculin from the E-cadherin-catenin complex, and this coincided with a robust phosphorylation of beta-catenin, plakoglobin/gamma-catenin, and p120(cas) on tyrosine residues. Furthermore, inactivation of the EGF receptor in serum-treated MDA-MB-468 cells with either a function-blocking antibody or EGF receptor kinase inhibitors mimicked the effects of serum starvation by stimulating both cellular aggregation and assembly of E-cadherin complexes with vinculin and actin. These results demonstrate that the EGF receptor directly regulates cell-cell adhesion through modulation of the interaction of E-cadherin with the actin cytoskeleton and thus substantiates the coordinate role of both of these molecules in tumor progression and metastasis.
Insights
Epidermal Growth Factor Receptor (EGFR) signaling disrupts E-cadherin-mediated cell adhesion by altering cytoskeletal connections. Inhibiting EGFR restores cell-cell adhesion, highlighting its role in tumor progression.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Alterations in cell adhesion and proliferation molecules are critical for tumor progression.
- Loss of E-cadherin and increased epidermal growth factor receptor (EGFR) expression are linked to tumorigenesis.
Purpose of the Study:
- To investigate the regulation of E-cadherin-dependent cell adhesion by epidermal growth factor (EGF) in MDA-MB-468 human breast cancer cells.
- To elucidate the molecular mechanisms underlying EGFR's influence on cell-cell adhesion and the actin cytoskeleton.
Main Methods:
- Examined changes in subcellular distribution of proteins connecting E-cadherin to the actin cytoskeleton.
- Utilized serum withdrawal, EGF treatment, function-blocking antibodies, and EGFR kinase inhibitors.
- Assessed E-cadherin-dependent cell aggregation and protein-protein interactions via co-precipitation.
Main Results:
- Serum withdrawal enhanced E-cadherin-mediated cell aggregation and actin-cytoskeletal component interactions in MDA-MB-468 cells.
- EGF treatment inhibited aggregation, dissociated actin and associated proteins from E-cadherin complexes, and induced tyrosine phosphorylation of catenins.
- EGFR inactivation mimicked serum withdrawal effects, restoring cell aggregation and cytoskeletal complex assembly.
Conclusions:
- EGFR directly regulates cell-cell adhesion by modulating E-cadherin's interaction with the actin cytoskeleton.
- The findings support a coordinated role for EGFR and E-cadherin in tumor progression and metastasis.